Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens

Models of In-Vivo Bacterial Infections for the Development of Antimicrobial Peptide-based Drugs

(2016) Jlenia Brunetti et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Immunomodulatory and Anti-inflammatory Activityin Vitroandin Vivoof a Novel Antimicrobial Candidate

(2016) Jlenia Brunetti et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate

(2016) Jlenia Brunetti et al.   Scientific Reports

Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant EnterobacteriaceaeIn Vitro

(2015) Odel Soren et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A lack of synergy between membrane-permeabilizing cationic antimicrobial peptides and conventional antibiotics

(2015) Jing He et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections

(2015) Matteo Bassetti et al.   Current Opinion in Critical Care

Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians

(2015) Pierluigi Viale et al.   CURRENT OPINION IN PHARMACOLOGY

Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options

(2015) Shio-Shin Jean et al.   Future Microbiology

Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase

(2014) Chiara Falciani et al.   AMINO ACIDS

Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae byIn VitroTime-Kill Experiments

(2014) T. Tängdén et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Synergistic Activities of Antimicrobial Peptide Brevinin-2CE with Five Kinds of Antibiotics Against Multidrug-Resistant Clinical Isolates

(2014) Yuan Zhang et al.   CURRENT MICROBIOLOGY

Update on the antibiotic resistance crisis

(2014) Gian Maria Rossolini et al.   CURRENT OPINION IN PHARMACOLOGY

Time–kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin

(2014) A. Safarika et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Aerosolized antibiotics in cystic fibrosis: an update

(2014) Stanley B Fiel   Expert Review of Respiratory Medicine

Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems

(2013) Oren Zusman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant KPC-Producing Klebsiella pneumoniae

(2013) Carlo Tascini et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of the colistin–rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria

(2013) Marcela Nastro et al.   JOURNAL OF CHEMOTHERAPY

In vitro Activities of the Novel Ceragenin CSA-13, Alone or in Combination with Colistin, Tobramycin, and Ciprofloxacin, against Pseudomonas aeruginosa Strains Isolated from Cystic Fibrosis Patients

(2012) Cagla Bozkurt-Guzel et al.   CHEMOTHERAPY

Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens

(2012) Chiara Falciani et al.   PLoS One

Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions

(2011) Alessandro Pini et al.   AMINO ACIDS

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Antibiotic adjuvants: multicomponent anti-infective strategies

(2011) Lindsay Kalan et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin

(2010) M. Vaara et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo

(2009) Alessandro Pini et al.   FASEB JOURNAL